The news reporters obtained a quote from the research from Mayo Clinic, "High costs of life-saving drugs are detrimental to both the personal finances of the individual patient, as well as society ...

ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in ...

Survival at five years was also significantly higher in the daratumumab group (93% vs. 86.9%). "These results are a major advancement in the treatment of high-risk smoldering multiple myeloma," says S ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Palliative care that recognizes patient goals and values is essential, starting at diagnos ...

A potential first-ever FDA-approved treatment for smoldering myeloma received a positive review from an advisory committee, but not without reservations, even from panelists who voted in favor. By a 6 ...

Dec 18 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...